This inventor holds 2 USPTO granted patents. Top assignee: Dr. Reddy's Laboratories, Incorporated. Active years: 2010-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Hyderabad, IN (2010)
- Warangal, IN (2011)
Company Filing History:

Years Active: 2010-2011
Title: Innovations of Vijayawardhan Chitta
Introduction
Vijayawardhan Chitta is a notable inventor based in Warangal, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for preparing complex chemical compounds. With a total of 2 patents to his name, his work has implications for the treatment of various medical conditions.
Latest Patents
Chitta's latest patents include a process for preparing (2R,3S/2S,3R)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol. This innovative process involves condensing 1-(2,4-difluorophenyl)-2-(1H-1,2,4-triazole-1-yl)ethanone with 4-chloro-6-ethyl-5-fluoropyrimidine in various solvents. Additionally, he has developed a process for preparing ziprasidone that minimizes impurities such as keto ziprasidone and hydroxy ziprasidone.
Career Highlights
Vijayawardhan Chitta is currently employed at Dr. Reddy's Laboratories, Incorporated, a leading pharmaceutical company. His work at this organization has allowed him to focus on innovative drug development and process optimization. His contributions have been instrumental in advancing the company's research initiatives.
Collaborations
Chitta has collaborated with several talented individuals in his field, including Venkateswarlu Muvva and Sundaram Venkataraman. These collaborations have fostered a productive environment for innovation and have led to the successful development of new pharmaceutical processes.
Conclusion
Vijayawardhan Chitta's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents and collaborations highlight his commitment to advancing medical science through effective drug development processes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile